DEVELOPMENT OF ALTERNATIVE AFFINITY CAPTURE REAGENTS FOR CANCE
Award amount
$149,857Program and phase
SBIR · Phase IAward year
2010Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- NECTAGEN INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- KAFMLCY56WM3
- Solicitation number
- PHS2010-1
- Topic code
- NCI
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development of Custom nanoCLAMP Affinity Chromatography Resins for Fast, Efficient Purification of Plasma Proteins
- Development of an Orally Available Therapeutic for Neutralizing C. difficile Toxin B
- Development of DNA-Labeled Antibody Mimetics as Low-Cost, High-Performance Reagents for Single Cell Analysis of Membrane Proteins
- Development of Enzyme Replacement Therapy for Complement C2-Deficiency
- Affinity reagents for the sub-fractionation of specific exosomal populations
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis
Research funding history
9 SBIR/STTR records share this UEI (2010–2024). Reported award amounts total $1,649,265. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services